Abstract
Purpose
To compare therapeutic decisions between 3 diagnostic protocols and to assess the need for in-person physical doctor–patient encounter in follow up and treatment of neovascular exudative age-related macular degeneration (AMD).
Methods
Analysis of 88 eyes of 88 unique patients with neovascular AMD who were routinely followed at our medical retina clinic. A retinal specialist reviewed all images in advance and wrote his decisions. He later attended an in-person encounters with all patients and documented his decisions. Masking was done by not exposing any identifying information to the specialist and by randomizing patient’s images order before the in-person encounter. Therapeutic decisions regarding intravitreal injections intervals and agent selection were made based on three protocols: (1) optic coherence tomography (OCT); (2) OCT/Ultra-widefield (UWF) color image; (3) OCT/UWF/full clinical exam. Visual acuity (VA) was incorporated into all protocols.
Results
We found an agreement of 93% between those protocols regarding the intervals of injections, and of 100% regarding injection agent selection. When comparing OCT, OCT/UWF and OCT/UWF/clinical exam guided decision making, there were no discrepancies between OCT and OCT/UWF. There were 6 out of 88 discrepancies (7%) between OCT/UWF and OCT/UWF/clinical exam. Of those 6 discrepancies, all were regarding intervals (Bland–Altman bias = − 0.2386). All discrepancies between OCT/UWF and OCT/UWF/Clinical exam were due to patients’ preferences, socioeconomic issues and fellow eye considerations, addressed during the face-to-face encounter with patients. Physical examination itself did not affect decision making.
Conclusions
Neovascular exudative AMD follow up and treatment decisions can be guided by VA and OCT, with UWF adding important information regarding macula and peripheral retina, but rarely affecting decision making. However, decision making may also be driven by patients’ preferences and other considerations that are being made only during the face-to-face visit and discussion. Thus, every approach supporting imaging only decision making, must take these factors into account.
Similar content being viewed by others
Data availability
Data is available and can be accessed via authors’ PC. Patient’s anonymity is protected.
References
Coleman HR, Chan CC, Ferris FL, Chew EY (2008) Age-related macular degeneration. Lancet, vol 372. pp 1835–1845
Kanagasingam Y, Bhuiyan A et al (2014) Progress on retinal image analysis for age related macular degeneration. Prog Retin Eye Res 38:20–42
Yoo TK, Choi JY et al (2019) The possibility of the combination of OCT and fundus images for improving the diagnostic accuracy of deep learning for age-related macular degeneration: a preliminary experiment. Med Bio Eng Comput 57(3):677–687
Wasser LM, Weill Y, Brosh K et al (2020) The Impact of COVID-19 on intravitreal injection compliance. SN Compr Clin Med 28:1–4
Billiote de Gage S, Droiun J, Desplas D (2021) Intravitreal anti–vascular endothelial growth factor use in france during the coronavirus disease 2019 pandemic. JAMA Ophthalmol 139(2):240–242
Brezzano M, Archana N, Arevalo F (2021) Frequency of urgent or emergent vitreoretinal surgical procedures in the United States during the covid-19 pandemic. JAMA Ophthalmol 139(4):456–463
Midena E, Frizziero L et al (2020) Optical coherence tomography and color fundus photography in the screening of age-related macular degeneration: a comparative, population-based study. PLoS ONE 15(8):e0237352
Graham KW, Chakravarthy U (2018) Identifying features of early and late age-related macular degeneration: a comparison of multicolor versus traditional color fundus photography. Retina 38(9):1751–1758
Quinn NB, Chakravarthy U et al (2018) Confocal infrared imaging with optical coherence tomography provides superior detection of a number of common macular lesions compared to colour fundus photography. Ophthalmic Physiol Opt 38(6):574–583
Ghemame M, Bon V et al (2020) Telemedicine monitoring for AMD patients. J Fr Ophthalmol 43(9):913–919
Fierson WM, Capone A, Granet DB, Blocker RJ, Bradford GE, Ellis GS et al (2015) Telemedicine for evaluation of retinopathy of prematurity. Pediatrics 135(1):e238–e254
Jani PD, Forbes L, Choudhury A, Preisser JS, Viera AJ, Garg S (2017) Evaluation of diabetic retinal screening and factors for ophthalmology referral in a telemedicine network. JAMA Ophthalmol 135(7):706–714
Clarke J, Puertas R, Kotecha A, Foster PJ, Barton K (2017) Virtual clinics in glaucoma care: face-to-face versus remote decision-making. Br J Ophthalmol 101(7):892–895
Starr MR, Barkmeier AJ, Engman SJ, Kitzmann A, Bakri SJ (2019) Telemedicine in the management of exudative age-related macular degeneration within an integrated health care system. Am J Ophthalmol 208:206–210
Andonegui J, Aliseda D, Serrano L, Eguzkiza A, Arruti N, Arias L et al (2016) Evaluation of a telemedicine model to follow up patients with exudative age-related macular degeneration. Retina 36(2):279–284
Brady CJ, Garg S (2020) Telemedicine for age-related macular degeneration. Telemed e-Health 26(4):565–568
Tsaousis KT, Empeslidis T, Konidaris VE, Kapoor B, Deane J (2016) The concept of virtual clinics in monitoring patients with age-related macular degeneration. Acta Ophthalmol 94(5):e353–e355
Aweidah H, Safadi K, Jotkowitz A, Chowers I, Levy J (2020) Hybrid telehealth medical retina clinic due to provider exposure and quarantine during covid-19 pandemic. Clin Ophthalmol 14:3421–3426
Trivizki O, Karp MR, Chawla A, Yamanuha J, Gregori G, Rosenfeld PJ (2020) Eliminating visual acuity and dilated fundus examinations improves cost efficiency of performing optical coherence tomogrpahy-guided intravitreal injections. Am J Ophthalmol 219:222–230
Zvi D, Zur D, Schwartz S, Cohen S, Saranga A, Loewenstein A, Goldstein M (2022) Additive value of a face-to-face visit to virtual remote decision in patients with neovascular age-related macular degeneration. Ophthalmologica. https://doi.org/10.1159/000522273
Patel Y, Miller DM, Fung AE, Hill LF, Rosenfeld PJ (2020) Are dilated fundus examinations needed for OCT-guided retreatment of exudative age-related macular degeneration? Ophthalmol Retina 4(2):141–147
Acknowledgements
This research was conducted as part of the requirements for MD degree in the School of Medicine, Hebrew University of Jerusalem.
Funding
None.
Author information
Authors and Affiliations
Contributions
Shilo Voichanski and Netanel Weinshtein analyzed and interpreted the patient data and wrote the manuscript. Yoel Hanhart contributed to writing the manuscript and reviewing tables and figures. All authors read and approved the final manuscript.
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no competing interests.
Ethical approval
This study protocol was reviewed and approved Helsinki IRB committee, Shaare Zedek Medical Center, Approval Number 0117–21-SZMC.
Consent to participate
Written informed consent from participants was not required in accordance with local guidelines.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Voichanski, S., Weinshtein, N. & Hanhart, J. Relative yield of retinal imaging versus clinical exam in following neovascular exudative age related macular degeneration. Int Ophthalmol 44, 126 (2024). https://doi.org/10.1007/s10792-024-03072-2
Received:
Accepted:
Published:
DOI: https://doi.org/10.1007/s10792-024-03072-2